$0.06
(1.37%)
Create an alert
Stocks and Shares ISAAVITA Medical, Inc. is a therapeutic acute wound care company. The Company solutions are designed to optimize wound healing, accelerate patient recovery, and improve clinical and economic outcomes across the continuum of acute wound management. Its technologies address critical healing needs arising from burns, traumatic injuries, and surgical repairs, through a portfolio and complementary products that support wound bed preparation, definitive closure, and recovery. Its portfolio includes RECELL and two complementary wound care products, PermeaDerm and Cohealyx. Its RECELL technology platform is an autologous cell harvesting technology that enables clinicians to create a suspension of a patient's own skin cells, called Spray-On Skin, at the point of care. Its PermeaDerm is a biosynthetic wound matrix that manufactures, markets, and distributes in the United States, under multi-year agreements with Stedical.
Company Information
About this company
Key people
Jan Stern Reed
Independent Non-Executive Chairman of the Board
Cary G. Vance
President, Chief Executive Officer, Executive Director
David O'Toole
Chief Financial Officer
Nicole Linda Kelsey
Senior Vice President - Human Resources, Chief Legal and Compliance Officer, Corporate Secretary
Joseph Fralin Woody
Non-Executive Director
Michael Tarnoff
Independent Director
Jeremy Curnock Cook
Independent Non-Executive Director
Suzanne Crowe
Independent Non-Executive Director
Click to see more
Key facts
- Shares in issue30.78m
- EPICRCEL
- ISINUS05380C1027
- LocationUnited States
- SectorHealthcare
- IndustryBiotechnology & Drugs
- Market cap$129.26m
- Employees226
- ExchangeNASDAQ
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.